Windtree Therapeutics Appoints New Directors and Officers
Ticker: WINTW · Form: 8-K · Filed: Aug 4, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
Windtree just swapped out board members and signed new deals with CEO/CFO.
AI Summary
Windtree Therapeutics, Inc. announced on July 29, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. David J. Glick and Mr. David M. S. Johnson, to its Board of Directors. Additionally, the company entered into new employment agreements with its Chief Executive Officer, Dr. Craig A. Fraser, and its Chief Financial Officer, Mr. Michael L. Smith, effective July 29, 2025.
Why It Matters
The election of new directors and the execution of new employment agreements signal potential strategic shifts and leadership stability for Windtree Therapeutics.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate strategic realignments or potential instability within the company.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Dr. David J. Glick (person) — Newly Elected Director
- Mr. David M. S. Johnson (person) — Newly Elected Director
- Dr. Craig A. Fraser (person) — Chief Executive Officer
- Mr. Michael L. Smith (person) — Chief Financial Officer
- July 29, 2025 (date) — Effective date of changes
FAQ
Who were the new directors elected to Windtree Therapeutics' Board?
Dr. David J. Glick and Mr. David M. S. Johnson were elected as new directors.
What is the effective date of the reported changes?
The earliest event reported is dated July 29, 2025.
Who are the key officers with new employment agreements?
Dr. Craig A. Fraser, Chief Executive Officer, and Mr. Michael L. Smith, Chief Financial Officer, have new employment agreements.
What is Windtree Therapeutics' state of incorporation?
Windtree Therapeutics, Inc. is incorporated in Delaware.
What is the SIC code for Windtree Therapeutics?
The Standard Industrial Classification code for Windtree Therapeutics is 2836, for Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 by Dr. David J. Glick regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).